Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Erratum: Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.

Boughey JC, Alvarado MD, Lancaster RB, Symmans WF, Mukhtar R, Wong JM, Ewing CA, Potter DA, Tuttle TM, Hieken TJ, Carter JM, Jakub JW, Kaplan HG, Buchanan CL, Jaskowiak NT, Sattar HA, Mueller J, Nanda R, Isaacs CJ, Pohlmann PR, Lynce F, Tousimis EA, Zeck JC, Lee MC, Lang JE, Mhawech-Fauceglia P, Rao R, Taback B, Goodellas C, Chen M, Kalinsky KM, Hibshoosh H, Killelea B, Sanft T, Hirst GL, Asare S, Matthews JB, Perlmutter J, Esserman LJ; I-SPY2 Investigators.

NPJ Breast Cancer. 2019 Jan 2;5:2. doi: 10.1038/s41523-018-0096-0. eCollection 2019.

2.

Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers.

Guindalini RSC, Zheng Y, Abe H, Whitaker K, Yoshimatsu TF, Walsh T, Schacht D, Kulkarni K, Sheth D, Verp MS, Bradbury AR, Churpek J, Obeid E, Mueller J, Khramtsova G, Liu F, Raoul A, Cao H, Romero IL, Hong S, Livingston R, Jaskowiak N, Wang X, Debiasi M, Pritchard CC, King MC, Karczmar G, Newstead GM, Huo D, Olopade OI.

Clin Cancer Res. 2019 Mar 15;25(6):1786-1794. doi: 10.1158/1078-0432.CCR-18-0200. Epub 2018 Aug 28.

PMID:
30154229
3.

Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.

Boughey JC, Alvarado MD, Lancaster RB, Fraser Symmans W, Mukhtar R, Wong JM, Ewing CA, Potter DA, Tuttle TM, Hieken TJ, Carter JM, Jakub JW, Kaplan HG, Buchanan CL, Jaskowiak NT, Sattar HA, Mueller J, Nanda R, Isaacs CJ, Pohlmann PR, Lynce F, Tousimis EA, Zeck JC, Lee MC, Lang JE, Mhawech-Fauceglia P, Rao R, Taback B, Chen M, Kalinsky KM, Hibshoosh H, Killelea B, Sanft T, Hirst GL, Asare S, Matthews JB, Perlmutter J, Esserman LJ; and I-SPY 2 Investigators.

NPJ Breast Cancer. 2018 Aug 17;4:26. doi: 10.1038/s41523-018-0074-6. eCollection 2018. Review. Erratum in: NPJ Breast Cancer. 2019 Jan 2;5:2.

4.

Lymph node wire localization post-chemotherapy: Towards improving the false negative sentinel lymph node biopsy rate in breast cancer patients.

Dashevsky BZ, Altman A, Abe H, Jaskowiak N, Bao J, Schacht DV, Sheth D, Kulkarni K.

Clin Imaging. 2018 Mar - Apr;48:69-73. doi: 10.1016/j.clinimag.2017.10.003. Epub 2017 Oct 7.

PMID:
29035756
5.

Attitudes and knowledge of urethral catheters: a targeted educational intervention.

Cohen A, Nottingham C, Packiam V, Jaskowiak N, Gundeti M.

BJU Int. 2016 Oct;118(4):654-9. doi: 10.1111/bju.13506. Epub 2016 May 18.

6.

Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes.

Huo D, Hou N, Jaskowiak N, Winchester DJ, Winchester DP, Yao K.

Ann Surg Oncol. 2015 Dec;22(13):4295-304. doi: 10.1245/s10434-015-4528-x. Epub 2015 Mar 28.

PMID:
25820998
7.

Synthesis and biological evaluation of 5'-glycyl derivatives of uridine as inhibitors of 1,4-β-galactosyltransferase.

Paszkowska J, Kral K, Bieg T, Żaba K, Węgrzyk K, Jaśkowiak N, Molinaro A, Silipo A, Wandzik I.

Bioorg Chem. 2015 Feb;58:18-25. doi: 10.1016/j.bioorg.2014.11.001. Epub 2014 Nov 10.

PMID:
25462623
8.

Utilization of radiotherapy for malignant phyllodes tumors: analysis of the National Cancer Data Base, 1998-2009.

Gnerlich JL, Williams RT, Yao K, Jaskowiak N, Kulkarni SA.

Ann Surg Oncol. 2014 Apr;21(4):1222-30. doi: 10.1245/s10434-013-3395-6. Epub 2013 Dec 4.

PMID:
24306659
9.

Operative risks associated with contralateral prophylactic mastectomy: a single institution experience.

Miller ME, Czechura T, Martz B, Hall ME, Pesce C, Jaskowiak N, Winchester DJ, Yao K.

Ann Surg Oncol. 2013 Dec;20(13):4113-20. doi: 10.1245/s10434-013-3108-1. Epub 2013 Jul 19.

PMID:
23868655
10.

Pre-mastectomy sentinel lymph node biopsy: a strategy to enhance outcomes in immediate breast reconstruction.

Teven C, Agarwal S, Jaskowiak N, Park JE, Chhablani A, Seitz IA, Song DH.

Breast J. 2013 Sep-Oct;19(5):496-503. doi: 10.1111/tbj.12151. Epub 2013 Jun 17.

PMID:
23773780
11.

Optimizing delivery of breast conservation therapy: a multidisciplinary approach to oncoplastic surgery.

Roughton MC, Shenaq D, Jaskowiak N, Park JE, Song DH.

Ann Plast Surg. 2012 Sep;69(3):250-5. doi: 10.1097/SAP.0b013e31822afa99.

PMID:
21862918
12.

Needle versus excisional biopsy for noninvasive and invasive breast cancer: report from the National Cancer Data Base, 2003-2008.

Williams RT, Yao K, Stewart AK, Winchester DJ, Turk M, Gorchow A, Jaskowiak N, Winchester DP.

Ann Surg Oncol. 2011 Dec;18(13):3802-10. doi: 10.1245/s10434-011-1808-y. Epub 2011 Jun 1.

PMID:
21630122
13.

Breast cancers not detected at MRI: review of false-negative lesions.

Shimauchi A, Jansen SA, Abe H, Jaskowiak N, Schmidt RA, Newstead GM.

AJR Am J Roentgenol. 2010 Jun;194(6):1674-9. doi: 10.2214/AJR.09.3568.

PMID:
20489112
14.

Aromatase inhibitors: an overview for surgeons.

Bickenbach KA, Jaskowiak N.

J Am Coll Surg. 2006 Sep;203(3):376-89. Epub 2006 Jul 13. Review. No abstract available.

PMID:
16931310
15.

Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.

Sahoo S, Recant WM, Jaskowiak N, Tong L, Heimann R.

Breast J. 2005 Jul-Aug;11(4):242-7.

PMID:
15982389
16.

Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma.

Murphy KT, Wardak A, Beckett MA, Lopez CA, Mehta N, Kimchi E, Salloum RM, Jaskowiak NT, Posner MC, Ohno T, Kufe DW, Weichselbaum RR, Mauceri HJ.

Cancer Chemother Pharmacol. 2005 Sep;56(3):317-21. Epub 2005 May 11.

PMID:
15887016
17.

Concomitant radiation therapy and paclitaxel for unresectable locally advanced breast cancer: results from two consecutive phase I/II trials.

Kao J, Conzen SD, Jaskowiak NT, Song DH, Recant W, Singh R, Masters GA, Fleming GF, Heimann R.

Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1045-53.

PMID:
15752883
18.

Selective gene expression using a DF3/MUC1 promoter in a human esophageal adenocarcinoma model.

Gupta VK, Park JO, Kurihara T, Koons A, Mauceri HJ, Jaskowiak NT, Kufe DW, Weichselbaum RR, Posner MC.

Gene Ther. 2003 Feb;10(3):206-12.

PMID:
12571627
19.

Combined gene therapy and ionizing radiation is a novel approach to treat human esophageal adenocarcinoma.

Gupta VK, Park JO, Jaskowiak NT, Mauceri HJ, Seetharam S, Weichselbaum RR, Posner MC.

Ann Surg Oncol. 2002 Jun;9(5):500-4.

PMID:
12052763
20.

Pitfalls of intraoperative quick parathyroid hormone monitoring and gamma probe localization in surgery for primary hyperparathyroidism.

Jaskowiak NT, Sugg SL, Helke J, Koka MR, Kaplan EL.

Arch Surg. 2002 Jun;137(6):659-68; discussion 668-9.

PMID:
12049536
21.

Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance.

Gupta VK, Jaskowiak NT, Beckett MA, Mauceri HJ, Grunstein J, Johnson RS, Calvin DA, Nodzenski E, Pejovic M, Kufe DW, Posner MC, Weichselbaum RR.

Cancer J. 2002 Jan-Feb;8(1):47-54.

PMID:
11895203
22.

Adenocarcinoma at a strictureplasty site in Crohn's disease: report of a case.

Jaskowiak NT, Michelassi F.

Dis Colon Rectum. 2001 Feb;44(2):284-7.

PMID:
11227948
23.

NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity.

Salloum RM, Jaskowiak NT, Mauceri HJ, Seetharam S, Beckett MA, Koons AM, Hari DM, Gupta VK, Reimer C, Kalluri R, Posner MC, Hellman S, Kufe DW, Weichselbaum RR.

Cancer Res. 2000 Dec 15;60(24):6958-63.

24.

Antitumor interaction of short-course endostatin and ionizing radiation.

Hanna NN, Seetharam S, Mauceri HJ, Beckett MA, Jaskowiak NT, Salloum RM, Hari D, Dhanabal M, Ramchandran R, Kalluri R, Sukhatme VP, Kufe DW, Weichselbaum RR.

Cancer J. 2000 Sep-Oct;6(5):287-93.

PMID:
11079167
25.

Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.

Gorski DH, Beckett MA, Jaskowiak NT, Calvin DP, Mauceri HJ, Salloum RM, Seetharam S, Koons A, Hari DM, Kufe DW, Weichselbaum RR.

Cancer Res. 1999 Jul 15;59(14):3374-8.

26.

The role of thyroid resection during reoperation for persistent or recurrent hyperparathyroidism.

Libutti SK, Bartlett DL, jaskowiak NT, Skarulis M, Marx SJ, Spiegel AM, Fraker DL, Doppman JL, Shawker TJ, Alexander HR.

Surgery. 1997 Dec;122(6):1183-7; discussion 1187-8.

PMID:
9426436
27.

Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia.

Sarraf P, Frederich RC, Turner EM, Ma G, Jaskowiak NT, Rivet DJ 3rd, Flier JS, Lowell BB, Fraker DL, Alexander HR.

J Exp Med. 1997 Jan 6;185(1):171-5.

28.

Is reoperation for gastrinoma excision indicated in Zollinger-Ellison syndrome?

Jaskowiak NT, Fraker DL, Alexander HR, Norton JA, Doppman JL, Jensen RT.

Surgery. 1996 Dec;120(6):1055-62; discussion 1062-3.

PMID:
8957495
29.

A prospective trial evaluating a standard approach to reoperation for missed parathyroid adenoma.

Jaskowiak N, Norton JA, Alexander HR, Doppman JL, Shawker T, Skarulis M, Marx S, Spiegel A, Fraker DL.

Ann Surg. 1996 Sep;224(3):308-20; discussion 320-1.

30.

A high-performance liquid chromatographic procedure for the determination of disaturated phosphatidylcholine in human plasma.

Sestak TL, Subbaiah PV, Jaskowiak NT, Bagdade JD.

Anal Biochem. 1990 Nov 15;191(1):156-9.

PMID:
2077937

Supplemental Content

Loading ...
Support Center